Tag: dermatology
May 9, 2018
Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
Foamix Pharmaceuticals (NASDAQ:FOMX) a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs... May 9, 2018
miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides
miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced new interim data... May 7, 2018
Aclaris Therapeutics Announces Availability of ESKATA (Hydrogen Peroxide) Topical Solution, 40% (w/w)
Aclaris Therapeutics (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that ESKATA™ is now available for purchase by dermatologists in the...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 6, 2018
Is this the Next Botox? Evolus’s Phase 3 Study Met Primary Endpoints
Botox has long been one the best solutions for smoothing wrinkle lines, managing skin breakouts, lifting lips and more, but... April 6, 2018
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical solution
Aclaris Therapeutics (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs... April 5, 2018